메뉴 건너뛰기




Volumn 42, Issue 2, 2010, Pages 613-616

The Future of Liver Transplantation

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE TRIPHOSPHATE; ANTIFUNGAL AGENT; ANTIINFECTIVE AGENT; ANTIVIRUS AGENT; BASILIXIMAB; CALCINEURIN INHIBITOR; CORTICOSTEROID; CYCLOSPORIN; DACLIZUMAB; IMMUNOSUPPRESSIVE AGENT; MAMMALIAN TARGET OF RAPAMYCIN INHIBITOR; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; TACROLIMUS;

EID: 77949438531     PISSN: 00411345     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.transproceed.2010.02.003     Document Type: Article
Times cited : (9)

References (25)
  • 1
    • 77949434467 scopus 로고    scopus 로고
    • National Organization of Transplants Accessed July 31, 2009
    • National Organization of Transplants. http://www.ont.es Accessed July 31, 2009
  • 2
    • 11244253101 scopus 로고    scopus 로고
    • Immunosuppression: towards a logical approach in liver transplantation
    • Perry I., and Neuberger J. Immunosuppression: towards a logical approach in liver transplantation. Clin Exp Inmunol 139 (2005) 2
    • (2005) Clin Exp Inmunol , vol.139 , pp. 2
    • Perry, I.1    Neuberger, J.2
  • 3
    • 33845516689 scopus 로고    scopus 로고
    • Mycophenolate mofetil in combination with reduction of calcineurin inhibitors for chronic renal dysfunction after liver transplantation
    • Pageaux G.P., Rostaing L., Calmus Y., et al. Mycophenolate mofetil in combination with reduction of calcineurin inhibitors for chronic renal dysfunction after liver transplantation. Liver Transpl 12 (2006) 1755
    • (2006) Liver Transpl , vol.12 , pp. 1755
    • Pageaux, G.P.1    Rostaing, L.2    Calmus, Y.3
  • 4
    • 22144442065 scopus 로고    scopus 로고
    • Mycophenolate mofetil combination therapy improves long-term outcomes after liver transplantation in patients with and without hepatitis C
    • Wiesner R.H., Shorr J.S., Steffen B.J., et al. Mycophenolate mofetil combination therapy improves long-term outcomes after liver transplantation in patients with and without hepatitis C. Liver Transpl 11 (2005) 750
    • (2005) Liver Transpl , vol.11 , pp. 750
    • Wiesner, R.H.1    Shorr, J.S.2    Steffen, B.J.3
  • 5
    • 77949480078 scopus 로고    scopus 로고
    • Conversion to mycophenolate mofetil combined with low doses of calcineurin inhibitors in liver transplant patients with chronic renal dysfunction
    • Pontón C., Vizcaíno L., Tomé S., et al. Conversion to mycophenolate mofetil combined with low doses of calcineurin inhibitors in liver transplant patients with chronic renal dysfunction. Transplantation 14 S1 (2008) S104
    • (2008) Transplantation , vol.14 , Issue.SUPPL.1
    • Pontón, C.1    Vizcaíno, L.2    Tomé, S.3
  • 6
    • 59249098555 scopus 로고    scopus 로고
    • Conversion to everolimus monotherapy in maintenance liver transplantation: feasibility, safety, and impact on renal function
    • De Simone P., Carrai P., Precisi A., et al. Conversion to everolimus monotherapy in maintenance liver transplantation: feasibility, safety, and impact on renal function. Transpl Int 22 (2009) 278
    • (2009) Transpl Int , vol.22 , pp. 278
    • De Simone, P.1    Carrai, P.2    Precisi, A.3
  • 7
    • 33746058731 scopus 로고    scopus 로고
    • Safety, tolerability, and efficacy of Everolimus in de novo liver transplant recipients12- and 36-month results
    • Levy G., Schmidli H., Punch J., et al. Safety, tolerability, and efficacy of Everolimus in de novo liver transplant recipients12- and 36-month results. Liver Transplant 12 (2006) 1640
    • (2006) Liver Transplant , vol.12 , pp. 1640
    • Levy, G.1    Schmidli, H.2    Punch, J.3
  • 8
    • 71249086317 scopus 로고    scopus 로고
    • Improvement of renal function after switching from calcineurin inhibitor to Everolimus in liver transplant recipients with chronic renal dysfunction
    • (in press)
    • Castroagudin J.F., Molina E., Romero R., et al. Improvement of renal function after switching from calcineurin inhibitor to Everolimus in liver transplant recipients with chronic renal dysfunction. Liver Transpl (2009) (in press)
    • (2009) Liver Transpl
    • Castroagudin, J.F.1    Molina, E.2    Romero, R.3
  • 9
    • 29544438901 scopus 로고    scopus 로고
    • Immunosupression in the immediate perioperative period after liver transplantation in patients with renal failure
    • Varo E., Bustamante M., and Fernández-Castroagudin J. Immunosupression in the immediate perioperative period after liver transplantation in patients with renal failure. Gastroenterol Hepatol 27 suppl 4 (2004) 87
    • (2004) Gastroenterol Hepatol , vol.27 , Issue.SUPPL. 4 , pp. 87
    • Varo, E.1    Bustamante, M.2    Fernández-Castroagudin, J.3
  • 10
    • 29544443396 scopus 로고    scopus 로고
    • Initial immunosupression in liver transplant recipients with impaired renal function
    • Varo E., López A., and Rivero C. Initial immunosupression in liver transplant recipients with impaired renal function. Transplant Proc 37 (2005) 3909
    • (2005) Transplant Proc , vol.37 , pp. 3909
    • Varo, E.1    López, A.2    Rivero, C.3
  • 11
    • 0035993621 scopus 로고    scopus 로고
    • Alternative immunosupression for acute renal failure in liver transplantation: role of ultra-low tacrolimus and basiliximab
    • Varo E., López A., Castroagudin J.F., et al. Alternative immunosupression for acute renal failure in liver transplantation: role of ultra-low tacrolimus and basiliximab. Transplant Proc 34 (2002) 1567
    • (2002) Transplant Proc , vol.34 , pp. 1567
    • Varo, E.1    López, A.2    Castroagudin, J.F.3
  • 12
    • 64349110801 scopus 로고    scopus 로고
    • Safety of an inmmunosupressant protocol based on sirolimus in liver transplant recipients with malignancies or high risk of tumor recurrence
    • Castroagudín J.F., Molina E., Tomé S., et al. Safety of an inmmunosupressant protocol based on sirolimus in liver transplant recipients with malignancies or high risk of tumor recurrence. Transplant Proc 41 (2009) 1003
    • (2009) Transplant Proc , vol.41 , pp. 1003
    • Castroagudín, J.F.1    Molina, E.2    Tomé, S.3
  • 13
    • 33846446070 scopus 로고    scopus 로고
    • Outcomes of adult-to-adult living donor liver transplantation: a single institution's experience wit 355 consecutive cases
    • Morioka D., Egawa H., Kasahara M., et al. Outcomes of adult-to-adult living donor liver transplantation: a single institution's experience wit 355 consecutive cases. Ann Surg 245 (2007) 315
    • (2007) Ann Surg , vol.245 , pp. 315
    • Morioka, D.1    Egawa, H.2    Kasahara, M.3
  • 14
    • 0033504039 scopus 로고    scopus 로고
    • Split liver transplantation
    • Busuttil R.W., and Goss J.A. Split liver transplantation. Ann Surg 229 (1999) 313
    • (1999) Ann Surg , vol.229 , pp. 313
    • Busuttil, R.W.1    Goss, J.A.2
  • 15
    • 27644521529 scopus 로고    scopus 로고
    • Donation after cardiac death: the University of Wisconsin experience with liver transplantation
    • Foley D.P., Fernandez L.A., Leverson G., et al. Donation after cardiac death: the University of Wisconsin experience with liver transplantation. Ann Surg 242 (2005) 724
    • (2005) Ann Surg , vol.242 , pp. 724
    • Foley, D.P.1    Fernandez, L.A.2    Leverson, G.3
  • 16
    • 0041620511 scopus 로고    scopus 로고
    • Extended criteria for organ accptance: strategies for achieving organ safety and for increasing organ pool
    • López-Navidad A., and Caballero F. Extended criteria for organ accptance: strategies for achieving organ safety and for increasing organ pool. Clin Transplant 17 (2003) 308
    • (2003) Clin Transplant , vol.17 , pp. 308
    • López-Navidad, A.1    Caballero, F.2
  • 17
    • 26444612184 scopus 로고    scopus 로고
    • Utilization of extended donor criteria liver allografts maximizes donor use and patient access to liver transplantation
    • Renz J.F., Kin C., Kinkhabwala M., et al. Utilization of extended donor criteria liver allografts maximizes donor use and patient access to liver transplantation. Ann Surg 242 (2005) 556
    • (2005) Ann Surg , vol.242 , pp. 556
    • Renz, J.F.1    Kin, C.2    Kinkhabwala, M.3
  • 18
    • 0037181644 scopus 로고    scopus 로고
    • Liver transplant with organs from elderly donors: Spanish experience with more than 300 livers donors over 70 years of age
    • Cuende N., Grande L., Sanjuán F., et al. Liver transplant with organs from elderly donors: Spanish experience with more than 300 livers donors over 70 years of age. Transplantation 73 (2002) 1360
    • (2002) Transplantation , vol.73 , pp. 1360
    • Cuende, N.1    Grande, L.2    Sanjuán, F.3
  • 19
    • 33747654443 scopus 로고    scopus 로고
    • Use of extended criteria livers decreases wait time for liver transplantation without adversely impacting posttransplant survival
    • Tector A.J., Mangus R.S., Chestovich P., et al. Use of extended criteria livers decreases wait time for liver transplantation without adversely impacting posttransplant survival. Ann Surg 244 (2006) 439
    • (2006) Ann Surg , vol.244 , pp. 439
    • Tector, A.J.1    Mangus, R.S.2    Chestovich, P.3
  • 20
    • 33845720040 scopus 로고    scopus 로고
    • Model for end-stage liver disease score-based allocation of donors for liver transplantation: a spanish multicenter experience
    • De la Mata M., Cuende D., Huet J., et al. Model for end-stage liver disease score-based allocation of donors for liver transplantation: a spanish multicenter experience. Transplantation 82 (2006) 1429
    • (2006) Transplantation , vol.82 , pp. 1429
    • De la Mata, M.1    Cuende, D.2    Huet, J.3
  • 21
    • 45549107328 scopus 로고    scopus 로고
    • Consensus document of the Spanish Society of Liver Transplantation
    • Sociedad Española de Trasplante Hepático
    • Sociedad Española de Trasplante Hepático. Consensus document of the Spanish Society of Liver Transplantation. Gastroenterol Hepatol 31 (2008) 82
    • (2008) Gastroenterol Hepatol , vol.31 , pp. 82
  • 22
    • 18544373877 scopus 로고    scopus 로고
    • Aplication of MARS artificial liver support as bridging therapy before split liver retransplantation in a 15-month-old child
    • Hommman M., Kasakow L.B., Geoghegan J., et al. Aplication of MARS artificial liver support as bridging therapy before split liver retransplantation in a 15-month-old child. Pediatr Transplant 6 (2002) 340
    • (2002) Pediatr Transplant , vol.6 , pp. 340
    • Hommman, M.1    Kasakow, L.B.2    Geoghegan, J.3
  • 23
    • 38949168818 scopus 로고    scopus 로고
    • Perfusion-decellularized matrix: using nature's platform to engineer a bioartificial heart
    • Ott H.C., Matthiesen T.S., Goh S.K., et al. Perfusion-decellularized matrix: using nature's platform to engineer a bioartificial heart. Taylor D. Nat Med 14 (2008) 213
    • (2008) Taylor D. Nat Med , vol.14 , pp. 213
    • Ott, H.C.1    Matthiesen, T.S.2    Goh, S.K.3
  • 24
    • 33845941584 scopus 로고    scopus 로고
    • Predictors of disease recurrence following neoadjuvant chemoradiotherapy and liver transplantation for unresectable perihilar cholangiocarcinoma
    • Heimbach J.K., Gores G.J., Haddock M.G., et al. Predictors of disease recurrence following neoadjuvant chemoradiotherapy and liver transplantation for unresectable perihilar cholangiocarcinoma. Transplantation 82 (2006) 1703
    • (2006) Transplantation , vol.82 , pp. 1703
    • Heimbach, J.K.1    Gores, G.J.2    Haddock, M.G.3
  • 25
    • 33847069207 scopus 로고    scopus 로고
    • Genomics and signaling pathways in hepatocellular carcinoma
    • Villanueva A., Newell P., Chiang D.Y., et al. Genomics and signaling pathways in hepatocellular carcinoma. Semin Liver Dis 27 (2007) 55
    • (2007) Semin Liver Dis , vol.27 , pp. 55
    • Villanueva, A.1    Newell, P.2    Chiang, D.Y.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.